This market snapshot provides an analysis of the global market for cardiac rhythm management (CRM) devices, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT-Ds). These implantable devices are used to restore the natural rhythm and function of the heart that can be impaired as a result of cardiac rhythm disorders and heart failure.
This market snapshot is intended to provide a high-level overview of the global CRM devices market, with key insights into:
- Unit volumes from 2022 to 2027
- Market forecasts from 2022 to 2027
- Competitive landscape analysis of major competitors
- Insights into key market events for strategies and startups
Companies Mentioned
- Abbott
- AtaCor Medical
- BioTrace Medical
- Biotronik
- Boston Scientific
- Cairdac
- Electroducer
- FineHeart
- Lepu medical
- LivaNova
- Medico
- Medtronic
- Merit Medical
- Microport Scientific
- Osypka Medical
- Pacetronix
